These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24507460)

  • 1. Beneficial role for supplemental vitamin D3 treatment in chronic urticaria: a randomized study.
    Rorie A; Goldner WS; Lyden E; Poole JA
    Ann Allergy Asthma Immunol; 2014 Apr; 112(4):376-82. PubMed ID: 24507460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does replacement of vitamin D reduce the symptom scores and improve quality of life in patients with chronic urticaria?
    Oguz Topal I; Kocaturk E; Gungor S; Durmuscan M; Sucu V; Yıldırmak S
    J Dermatolog Treat; 2016; 27(2):163-6. PubMed ID: 26295454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D supplementation: a potential booster for urticaria therapy.
    Rorie A; Poole JA
    Expert Rev Clin Immunol; 2014 Oct; 10(10):1269-71. PubMed ID: 25155458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
    Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB
    J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E; Colanardi MC; Paradiso MT; Ferrannini A
    Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of vitamin D add-on therapy on the improvement of quality of life and clinical symptoms of patients with chronic spontaneous urticaria.
    Nabavizadeh SH; Alyasin S; Esmaeilzadeh H; Mosavat F; Ebrahimi N
    Asian Pac J Allergy Immunol; 2023 Jun; 41(2):150-157. PubMed ID: 32828116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial.
    Witham MD; Price RJ; Struthers AD; Donnan PT; Messow CM; Ford I; McMurdo ME
    JAMA Intern Med; 2013 Oct; 173(18):1672-9. PubMed ID: 23939263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of cetirizine versus cetirizine plus ranitidine in chronic urticaria: Double-blind randomized placebo-controlled study.
    Guevara-Gutierrez E; Bonilla-Lopez S; Hernández-Arana S; Tlacuilo-Parra A
    J Dermatolog Treat; 2015; 26(6):548-50. PubMed ID: 25886090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial.
    Derakhshandi H; Etemadifar M; Feizi A; Abtahi SH; Minagar A; Abtahi MA; Abtahi ZA; Dehghani A; Sajjadi S; Tabrizi N
    Acta Neurol Belg; 2013 Sep; 113(3):257-63. PubMed ID: 23250818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial).
    Schroten NF; Ruifrok WP; Kleijn L; Dokter MM; Silljé HH; Lambers Heerspink HJ; Bakker SJ; Kema IP; van Gilst WH; van Veldhuisen DJ; Hillege HL; de Boer RA
    Am Heart J; 2013 Aug; 166(2):357-364.e2. PubMed ID: 23895820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trial.
    Binkley N; Ringe JD; Reed JI; Ljunggren O; Holick MF; Minne HW; Liu M; Lamotta A; West JA; Santora AC
    Bone; 2009 Apr; 44(4):639-47. PubMed ID: 19185560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial.
    Smolders J; Hupperts R; Barkhof F; Grimaldi LM; Holmoy T; Killestein J; Rieckmann P; Schluep M; Vieth R; Hostalek U; Ghazi-Visser L; Beelke M;
    J Neurol Sci; 2011 Dec; 311(1-2):44-9. PubMed ID: 21620416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Add-on montelukast in antihistamine-resistant chronic idiopathic urticaria.
    Kosnik M; Subic T
    Respir Med; 2011 Oct; 105 Suppl 1():S84-8. PubMed ID: 22015095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD.
    Kooienga L; Fried L; Scragg R; Kendrick J; Smits G; Chonchol M
    Am J Kidney Dis; 2009 Mar; 53(3):408-16. PubMed ID: 19185400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of High-Dose Supplementation With Oral Vitamin D3 on Depressive Symptoms in Dialysis Patients With Vitamin D3 Insufficiency: A Prospective, Randomized, Double-Blind Study.
    Wang Y; Liu Y; Lian Y; Li N; Liu H; Li G
    J Clin Psychopharmacol; 2016 Jun; 36(3):229-35. PubMed ID: 27022679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
    Leventis P; Kiely PD
    Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin and tranexamic Acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot study.
    Asero R; Tedeschi A; Cugno M
    Int Arch Allergy Immunol; 2010; 152(4):384-9. PubMed ID: 20203527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia.
    Collins N; Maher J; Cole M; Baker M; Callaghan N
    Q J Med; 1991 Feb; 78(286):113-22. PubMed ID: 1851568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.